市場調査レポート
商品コード
1784613

アジア太平洋の手術用抗菌縫合糸市場の予測 (2021~2031年):市場範囲・セグメント・動向・競合分析

Asia Pacific Antimicrobial Surgical Suture Market Report 2021-2031 by Scope, Segmentation, Dynamics, and Competitive Analysis


出版日
ページ情報
英文 124 Pages
納期
即納可能 即納可能とは
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=149.46円
アジア太平洋の手術用抗菌縫合糸市場の予測 (2021~2031年):市場範囲・セグメント・動向・競合分析
出版日: 2025年07月10日
発行: The Insight Partners
ページ情報: 英文 124 Pages
納期: 即納可能 即納可能とは
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

アジア太平洋の手術用抗菌縫合糸の市場規模は、2023年の5,168万米ドルから2031年には1億2,473万米ドルに達すると予測されています。同市場は2024年から2031年にかけて11.7%のCAGRを記録すると推定されます。

エグゼクティブサマリーとアジア太平洋の手術用抗菌縫合糸市場分析

アジア太平洋の手術用抗菌縫合糸市場は、さらに中国、日本、インド、オーストラリア、韓国、その他アジア太平洋に区分されます。この地域は、手術用抗菌縫合糸の世界のシナリオで最も急成長している市場です。アジア太平洋は予測期間中に最も高い成長が見込まれます。

この地域の手術用抗菌縫合糸市場は、整形手術の増加や、中国やインドなどの新興国における医療ツーリズム需要の増加などの要因によって成長すると予想されます。さらに、分析件数の増加や医療費の急増が、予測期間中の市場成長を促進すると予想されます。

アジア太平洋の手術用抗菌縫合糸市場のセグメンテーション分析:

手術用抗菌縫合糸市場の分析に貢献した主要セグメントは、種類、原材料、用途、エンドユーザーです。

種類別では、アジア太平洋の手術用抗菌縫合糸市場は、トリクロサン抗菌縫合糸とクロルヘキシジン抗菌縫合糸に二分されます。2023年にはトリクロサン抗菌縫合糸が大きなシェアを占めています。

原材料別では、アジア太平洋の手術用抗菌縫合糸市場はポリグラクチン910抗菌縫合糸、ポリグルカプロン25、ポリグリコール酸に区分されます。2023年にはポリグラクチン910抗菌縫合糸セグメントが最大シェアを占めています。

用途別では、アジア太平洋の手術用抗菌縫合糸市場は、心臓血管外科、一般外科、眼科外科、婦人科外科、整形外科、形成外科、獣医外科、歯科外科、その他に区分されます。2023年には、心臓血管外科セグメントが市場で最大のシェアを占めています。

エンドユーザー別では、アジア太平洋の手術用抗菌縫合糸市場は病院、外来手術センター、その他に区分されます。2023年には病院セグメントが最大シェアを占めています。

アジア太平洋の手術用抗菌縫合糸市場の展望

RMIT Centre for Materials Innovation and Future Fashionは、手術部位感染の蔓延を減らすため、新しいスマートな抗菌縫合糸の開発に注力している組織の一つです。同センターの縫合糸製品は、医療画像処理中に光る素材から作られています。これらの縫合糸は、有望な代替品としてメッシュインプラントに取って代わる可能性を秘めています。これらの縫合糸は、体温で6時間接触すると感染症を予防し、高度薬剤耐性菌の99%を死滅させるという優れた抗菌特性に加えて、患者の回復経過をモニターする上でも有益です。また、術前画像診断でメッシュの位置を正確に視覚化できるため、手術時間を大幅に短縮し、手術精度全般を向上させる可能性もあります。

MITの技術者たちは、組織を固定するだけでなく、炎症を感知して薬剤を送達できる「スマート」縫合糸を開発しました。この新しい縫合糸は動物の組織から作られており、古代ローマ人によって作られた「キャットガット」縫合糸に似ています。この縫合糸はハイドロゲルでコーティングされており、センサーや薬物、あるいは治療物質を放出する細胞と一体化させることができます。この縫合糸は、過剰な瘢痕や炎症のために大腸切除術を受ける必要があるクローン病患者の治療に特に有益である可能性があります。MITのスマート縫合糸は組織を所定の位置に固定し、炎症が再封された腸の不適切な機能を示す早期警告サインであることを識別します。この縫合糸のハイドロゲルコーティングは、PLAやPLGAといったFDA認可のポリマーで構成された微粒子を通して薬剤を運び、薬剤放出速度の制御も助ける。このアプローチは、化学療法薬や抗生物質など、他の薬物の送達にも使用できます。したがって、スマート手術用抗菌縫合糸の開発は、今後数年間、手術用抗菌縫合糸市場の成長に新たな成長動向をもたらすと予想されます。

アジア太平洋の手術用抗菌縫合糸市場 - 国別分析

国別に見ると、アジア太平洋の手術用抗菌縫合糸市場は、日本、中国、インド、韓国、オーストラリア、その他アジア太平洋で構成されています。2023年には中国が最大のシェアを占めています。

中国は、アメリカを除くどの国よりも多くの整形手術を行っています。ある報告書によると、中国では2020年に2,200万件以上の整形手術が行われました。これは、ライセンシングを受けた形成外科医が行った手術のみを含むものであり、中国にはライセンシングを受けていない形成外科医が存在するため、もっと多いと思われます。中国の自己イメージに対する考え方の変化、富の増大、技術の進歩、有名人文化への執着が、この成長を後押ししています。中国では、就職希望者は応募時に写真の提出を求められることが多いため、競争の激しい中堅レベルの職場では、美貌が有利に働くと考えられています。

形成外科手術のほか、整形外科手術や一般外科手術も中国の病院用縫合糸市場を牽引しています。2020年8月、北京海淀病院は2020年5月に整形外科手術ロボットを正式に導入し、2021年8月末までに400件以上のロボット手術を完了しました。この整形外科手術ロボットは、患者の解剖学的構造や脊椎と股関節の関係を動的に分析し、個々に合わせた手術計画を計画通りに正確に実行することができます。

アジア太平洋の手術用抗菌縫合糸市場 - 企業プロファイル

市場で事業を展開する主要企業には、Advanced MedTech Solutions Pvt. Ltd.;Futura Surgicare Pvt Ltd(Dolphin Sutures);Healthium Medtech Limited;Internacional Farmaceutica SA;Johnson &Johnson;Meril Life Sciences Pvt Ltd;TI Medicalなどがあります。これらの企業は、消費者に革新的な製品を提供し、市場シェアを拡大するために、事業拡大、製品革新、M&Aなど様々な戦略を採用しています。

アジア太平洋の手術用抗菌縫合糸市場の分析手法:

本レポートで紹介するデータの収集と分析には、以下の分析手法を採用しています:

二次分析:分析プロセスは、各市場の質的・量的データを収集するために、社内外の情報源を活用した包括的な二次分析から始まります。一般的に参照される二次分析情報源は以下の通りであるが、これらに限定されるものではない:

企業のウェブサイト、年次報告書、財務諸表、ブローカーの分析、投資家のプレゼンテーション。業界専門誌、その他関連出版物政府文書、統計データベース、市場レポートニュース記事、プレスリリース、ウェブキャスト。なお、企業プロファイルに含まれる財務データはすべて米ドルに統一されています。他の通貨で報告されている企業の数値は、該当年の関連為替レートを使用して米ドルに換算されています。

1次分析:インサイト・パートナーズでは、データ分析を検証し、貴重な知見を得るために、毎年、業界利害関係者や専門家に相当数の1次インタビューを実施しています。これらの分析は、以下を目的としています:

2次分析の結果を検証し、改良します。分析チームの専門知識と市場理解を深める。市場規模、動向、成長パターン、競合力学、将来の見通しに関する考察を得る。1次分析は、様々な市場、カテゴリー、セグメント、サブセグメントを対象とし、Eメールでのやり取りや電話インタビューで実施します。参加者は通常以下の通りです:

業界利害関係者(副社長、事業開拓マネージャー、マーケット・インテリジェンス・マネージャー、国内営業マネージャー、外部専門家)、評価の専門家(リサーチアナリスト、国内営業マネージャー、評価専門家、分析アナリスト、業界固有の専門知識を持つ主要オピニオンリーダー)

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

  • 主要洞察

第3章 分析手法

  • 二次分析
  • 一次分析
    • 仮説の策定
    • マクロ経済要因分析
    • 基礎数値の動向
    • データの三角測量
    • 国レベルのデータ

第4章 アジア太平洋の手術用抗菌縫合糸市場:主要市場力学

  • 市場促進要因
    • 手術部位感染の急増
    • 慢性創傷および手術症例の増加
  • 市場抑制要因
    • 縫合糸に代わる非侵襲的な方法
  • 市場機会
    • 手術用抗菌縫合糸における戦略的取り組み
  • 今後の動向
    • スマート抗菌縫合糸
  • 促進要因と抑制要因の影響

第5章 手術用抗菌縫合糸市場:アジア太平洋市場の分析

  • アジア太平洋の手術用抗菌縫合糸市場の収益(2021~2031年)
  • アジア太平洋の手術用抗菌縫合糸市場の予測分析

第6章 アジア太平洋の手術用抗菌縫合糸市場の分析:種類別

  • トリクロサン抗菌縫合糸
  • クロルヘキシジン抗菌縫合糸

第7章 アジア太平洋の手術用抗菌縫合糸の市場分析:原材料別

  • ポリグラクチン910抗菌縫合糸
  • ポリグルカプロン25
  • ポリグリコール酸

第8章 アジア太平洋の手術用抗菌縫合糸の市場分析:用途別

  • 心臓血管外科
  • 一般外科
  • 眼科手術
  • 婦人科外科
  • 整形外科
  • 形成外科
  • 獣医外科
  • 歯科外科
  • その他

第9章 アジア太平洋の手術用抗菌縫合糸市場の分析:エンドユーザー別

  • 病院
  • 外来手術センター
  • その他

第10章 アジア太平洋の手術用抗菌縫合糸市場:国別分析

  • アジア太平洋
    • 日本
    • 中国
    • インド
    • 韓国
    • オーストラリア
    • その他アジア太平洋

第11章 業界情勢

  • 成長戦略
  • 企業シェア分析(%、2023年)

第12章 企業プロファイル

  • TI Medical
  • Healthium Medtech Limited
  • Meril Life Sciences Pvt Ltd
  • Johnson & Johnson
  • Futura Surgicare Pvt Ltd(Dolphin Sutures)
  • Advanced MedTech Solutions Pvt. Ltd.
  • Internacional Farmaceutica SA

第13章 付録

図表

List Of Tables

  • Table 1. Asia Pacific Antimicrobial Surgical Suture Market Segmentation
  • Table 2. Asia Pacific Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
  • Table 3. Japan: Asia Pacific Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 4. Japan: Asia Pacific Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031(US$ Million) - by Raw Materials
  • Table 5. Japan: Asia Pacific Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 6. Japan: Asia Pacific Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031(US$ Million) - by End User
  • Table 7. China: Asia Pacific Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 8. China: Asia Pacific Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031(US$ Million) - by Raw Materials
  • Table 9. China: Asia Pacific Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 10. China: Asia Pacific Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031(US$ Million) - by End User
  • Table 11. India: Asia Pacific Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 12. India: Asia Pacific Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031(US$ Million) - by Raw Materials
  • Table 13. India: Asia Pacific Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 14. India: Asia Pacific Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031(US$ Million) - by End User
  • Table 15. South Korea: Asia Pacific Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 16. South Korea: Asia Pacific Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031(US$ Million) - by Raw Materials
  • Table 17. South Korea: Asia Pacific Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 18. South Korea: Asia Pacific Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031(US$ Million) - by End User
  • Table 19. Australia: Asia Pacific Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 20. Australia: Asia Pacific Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031(US$ Million) - by Raw Materials
  • Table 21. Australia: Asia Pacific Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 22. Australia: Asia Pacific Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031(US$ Million) - by End User
  • Table 23. Rest of APAC: Asia Pacific Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 24. Rest of APAC: Asia Pacific Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031(US$ Million) - by Raw Materials
  • Table 25. Rest of APAC: Asia Pacific Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 26. Rest of APAC: Asia Pacific Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031(US$ Million) - by End User
  • Table 27. Recent Growth Strategies in Asia Pacific Antimicrobial Surgical Suture Market
  • Table 28. Glossary of Terms, Antimicrobial Surgical Suture Market

List Of Figures

  • Figure 1. Asia Pacific Antimicrobial Surgical Suture Market Segmentation, by Country
  • Figure 2. Asia Pacific Antimicrobial Surgical Suture Market - Key Market Dynamics
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. Asia Pacific Antimicrobial Surgical Suture Market Revenue (US$ Million), 2021-2031
  • Figure 5. Asia Pacific Antimicrobial Surgical Suture Market Share (%) - by Type (2023 and 2031)
  • Figure 6. Triclosan Antimicrobial Suture: Asia Pacific Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 7. Chlorhexidine Antimicrobial Suture: Asia Pacific Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 8. Asia Pacific Antimicrobial Surgical Suture Market Share (%) - by Raw Materials (2023 and 2031)
  • Figure 9. Polyglactin 910 Antimicrobial Suture: Asia Pacific Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 10. Poliglecaprone 25: Asia Pacific Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 11. Polyglycolic Acid: Asia Pacific Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 12. Asia Pacific Antimicrobial Surgical Suture Market Share (%) - by Application (2023 and 2031)
  • Figure 13. Cardiovascular Surgery: Asia Pacific Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 14. General Surgery: Asia Pacific Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 15. Ophthalmic Surgery: Asia Pacific Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 16. Gynaecological Surgery: Asia Pacific Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 17. Orthopedic Surgery: Asia Pacific Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 18. Plastic Surgery: Asia Pacific Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 19. Veterinary Surgery: Asia Pacific Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 20. Dental Surgery: Asia Pacific Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 21. Others: Asia Pacific Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 22. Asia Pacific Antimicrobial Surgical Suture Market Share (%) - by End User (2023 and 2031)
  • Figure 23. Hospitals: Asia Pacific Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 24. Ambulatory Surgical Centers: Asia Pacific Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 25. Others: Asia Pacific Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 26. Asia Pacific Antimicrobial Surgical Suture Market Breakdown, by Key Countries - Revenue (2023) (US$ Million)
  • Figure 27. Asia Pacific Antimicrobial Surgical Suture Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 28. Japan: Asia Pacific Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 29. China: Asia Pacific Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 30. India: Asia Pacific Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 31. South Korea: Asia Pacific Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 32. Australia: Asia Pacific Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 33. Rest of APAC: Asia Pacific Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031(US$ Million)
目次
Product Code: BMIRE00031799

The Asia Pacific antimicrobial surgical suture market size is expected to reach US$ 124.73 million by 2031 from US$ 51.68 million in 2023. The market is estimated to record a CAGR of 11.7% from 2024-2031.

Executive Summary and Asia Pacific Antimicrobial Surgical Suture Market Analysis:

The Asia Pacific antimicrobial surgical suture market is further segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. This region is the fastest-growing market for antimicrobial surgical sutures in global scenarios. Asia Pacific is expected to witness the highest growth over the forecast period.

The antimicrobial surgical suture market in this region is expected to grow owing to factors such as rising plastic surgeries and increasing demand for medical tourism in emerging economies such as China and India. Moreover, the increase in the number of research studies and the surge in healthcare expenditure are anticipated to fuel the market growth during the forecast period.

Asia Pacific Antimicrobial Surgical Suture Market Segmentation Analysis:

Key segments that contributed to the derivation of the antimicrobial surgical suture market analysis are type, raw materials, application, and end user.

Based on type, the Asia Pacific antimicrobial surgical suture market is bifurcated into triclosan antimicrobial suture and chlorhexidine antimicrobial suture. The triclosan antimicrobial suture held a larger share of the market in 2023.

By raw materials, the Asia Pacific antimicrobial surgical suture market is segmented into polyglactin 910 antimicrobial suture, poliglecaprone 25, and polyglycolic acid. The polyglactin 910 antimicrobial suture segment held the largest share of the market in 2023.

By application, the Asia Pacific antimicrobial surgical suture market is segmented into cardiovascular surgery, general surgery, ophthalmic surgery, gynaecological surgery, orthopedic surgery, plastic surgery, veterinary surgery, dental surgery, and others. The cardiovascular surgery segment held the largest share of the market in 2023.

By end user, the Asia Pacific antimicrobial surgical suture market is segmented into hospitals, ambulatory surgical centers, and others. The hospitals segment held the largest share of the market in 2023.

Asia Pacific Antimicrobial Surgical Suture Market Outlook

The RMIT Centre for Materials Innovation and Future Fashion is one of the organizations focusing on developing new, smart antimicrobial sutures to reduce the prevalence of surgical site infections. The center's suture products are made from materials that glow during medical imaging procedures; these stitches have the potential to replace mesh implants as promising alternatives. They can be beneficial in monitoring patient recovery progress, in addition to their impressive antimicrobial properties, preventing infections and killing 99% of highly drug-resistant bacteria after 6 hours of contact at body temperature. It may also significantly reduce surgery duration and increase surgical accuracy in general through the ability to visualize mesh location accurately on preoperative imaging.

MIT engineers have created "smart" sutures that can not only hold tissues in place but also sense inflammation and deliver drugs. The new sutures are made from animal tissue, similar to the "catgut" sutures created by the ancient Romans. These sutures are coated with hydrogels that can be integrated with sensors, drugs, or even cells that release therapeutic substances. These sutures could be particularly beneficial for the treatment of Crohn's disease patients who need to undergo colectomy due to excessive scarring or inflammation. MIT's smart sutures hold the tissue in place and identify inflammation as an early warning sign indicating the improper functioning of the resealed intestines. The hydrogel coating of these sutures carries drugs through microparticles composed of FDA-approved polymers such as PLA and PLGA, which also aid in a controlled drug release rate. This approach could also be used to deliver other drugs, such as chemotherapy drugs or antibiotics. Therefore, developments in smart antimicrobial surgical sutures are expected to bring new growth trends in the antimicrobial surgical sutures market growth in the coming years.

Asia Pacific Antimicrobial Surgical Suture Market Country Insights

Based on country, the Asia Pacific antimicrobial surgical suture market comprises Japan, China, India, South Korea, Australia, and the Rest of Asia Pacific. China held the largest share in 2023.

China performs more plastic surgery operations than any country except America. According to a report, over 22 million plastic surgeries were performed in China in 2020. This includes only the procedures performed by licensed plastic surgeons, which is likely higher due to the presence of unlicensed plastic surgeons in China. China's changing attitudes toward self-image, growing wealth, technological advancements, and obsession with celebrity culture fuel this growth. In China, beauty is deemed an advantage in the competitive mid-level workplace because job applicants are often required to submit a photograph with their application.

Apart from Plastic surgeries, orthopedic and general surgeries are also propelling the market for hospital sutures in China. In August 2020, Beijing Haidian Hospital officially introduced orthopedic surgery robots in May 2020 and completed more than 400 robotic surgeries by the end of August 2021. The orthopedic surgical robot could dynamically analyze the patient's anatomy and the spine-hip relation and carry out individualized surgery planning precisely as planned.

Asia Pacific Antimicrobial Surgical Suture Market Company Profiles

Some of the key players operating in the market include Advanced MedTech Solutions Pvt. Ltd.; Futura Surgicare Pvt Ltd (Dolphin Sutures); Healthium Medtech Limited; Internacional Farmaceutica SA; Johnson & Johnson; Meril Life Sciences Pvt Ltd; and TI Medical among others. These players are adopting various strategies such as expansion, product innovation, and mergers and acquisitions to provide innovative products to their consumers and increase their market share.

Asia Pacific Antimicrobial Surgical Suture Market Research Methodology :

The following methodology has been followed for the collection and analysis of data presented in this report:

Secondary Research The research process begins with comprehensive secondary research, utilizing both internal and external sources to gather qualitative and quantitative data for each market. Commonly referenced secondary research sources include, but are not limited to:

Company websites , annual reports, financial statements, broker analyses, and investor presentations. Industry trade journals and other relevant publications. Government documents , statistical databases, and market reports. News articles , press releases, and webcasts specific to companies operating in the market. Note: All financial data included in the Company Profiles section has been standardized to USD. For companies reporting in other currencies, figures have been converted to USD using the relevant exchange rates for the corresponding year.

Primary Research The Insight Partners' conducts a significant number of primary interviews each year with industry stakeholders and experts to validate its data analysis, and gain valuable insights. These research interviews are designed to:

Validate and refine findings from secondary research. Enhance the expertise and market understanding of the analysis team. Gain insights into market size, trends, growth patterns, competitive dynamics, and future prospects. Primary research is conducted via email interactions and telephone interviews, encompassing various markets, categories, segments, and sub-segments across different regions. Participants typically include:

Industry stakeholders : Vice Presidents, business development managers, market intelligence managers, and national sales managers External experts : Valuation specialists, research analysts, and key opinion leaders with industry-specific expertise

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Secondary Research
  • 3.2 Primary Research
    • 3.2.1 Hypothesis formulation:
    • 3.2.2 Macro-economic factor analysis:
    • 3.2.3 Developing base number:
    • 3.2.4 Data Triangulation:
    • 3.2.5 Country level data:

4. Asia Pacific Antimicrobial Surgical Suture Market - Key Market Dynamics

  • 4.1 Market Drivers:
    • 4.1.1 Surging Prevalence of Surgical Site Infections
    • 4.1.2 Increasing Cases of Chronic Wounds and Surgeries
  • 4.2 Market Restraints
    • 4.2.1 Non-invasive Alternatives to Stitches
  • 4.3 Market Opportunities
    • 4.3.1 Strategic Initiatives in Antimicrobial Surgical Suture
  • 4.4 Future Trends
    • 4.4.1 Smart Antimicrobial Sutures
  • 4.5 Impact of Drivers and Restraints:

5. Antimicrobial Surgical Suture Market - Asia Pacific Market Analysis

  • 5.1 Asia Pacific Antimicrobial Surgical Suture Market Revenue (US$ Million), 2021-2031
  • 5.2 Asia Pacific Antimicrobial Surgical Suture Market Forecast Analysis

6. Asia Pacific Antimicrobial Surgical Suture Market Analysis - by Type

  • 6.1 Triclosan Antimicrobial Suture
    • 6.1.1 Overview
    • 6.1.2 Triclosan Antimicrobial Suture: Asia Pacific Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
  • 6.2 Chlorhexidine Antimicrobial Suture
    • 6.2.1 Overview
    • 6.2.2 Chlorhexidine Antimicrobial Suture: Asia Pacific Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)

7. Asia Pacific Antimicrobial Surgical Suture Market Analysis - by Raw Materials

  • 7.1 Polyglactin 910 Antimicrobial Suture
    • 7.1.1 Overview
    • 7.1.2 Polyglactin 910 Antimicrobial Suture: Asia Pacific Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.2 Poliglecaprone 25
    • 7.2.1 Overview
    • 7.2.2 Poliglecaprone 25: Asia Pacific Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.3 Polyglycolic Acid
    • 7.3.1 Overview
    • 7.3.2 Polyglycolic Acid: Asia Pacific Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)

8. Asia Pacific Antimicrobial Surgical Suture Market Analysis - by Application

  • 8.1 Cardiovascular Surgery
    • 8.1.1 Overview
    • 8.1.2 Cardiovascular Surgery: Asia Pacific Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.2 General Surgery
    • 8.2.1 Overview
    • 8.2.2 General Surgery: Asia Pacific Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.3 Ophthalmic Surgery
    • 8.3.1 Overview
    • 8.3.2 Ophthalmic Surgery: Asia Pacific Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.4 Gynaecological Surgery
    • 8.4.1 Overview
    • 8.4.2 Gynaecological Surgery: Asia Pacific Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.5 Orthopedic Surgery
    • 8.5.1 Overview
    • 8.5.2 Orthopedic Surgery: Asia Pacific Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.6 Plastic Surgery
    • 8.6.1 Overview
    • 8.6.2 Plastic Surgery: Asia Pacific Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.7 Veterinary Surgery
    • 8.7.1 Overview
    • 8.7.2 Veterinary Surgery: Asia Pacific Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.8 Dental Surgery
    • 8.8.1 Overview
    • 8.8.2 Dental Surgery: Asia Pacific Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.9 Others
    • 8.9.1 Overview
    • 8.9.2 Others: Asia Pacific Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)

9. Asia Pacific Antimicrobial Surgical Suture Market Analysis - by End User

  • 9.1 Hospitals
    • 9.1.1 Overview
    • 9.1.2 Hospitals: Asia Pacific Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.2 Ambulatory Surgical Centers
    • 9.2.1 Overview
    • 9.2.2 Ambulatory Surgical Centers: Asia Pacific Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.3 Others
    • 9.3.1 Overview
    • 9.3.2 Others: Asia Pacific Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)

10. Asia Pacific Antimicrobial Surgical Suture Market - Country Analysis

  • 10.1 Asia Pacific
    • 10.1.1 Asia Pacific Antimicrobial Surgical Suture Market Overview
    • 10.1.2 Asia Pacific Antimicrobial Surgical Suture Market - Revenue and Forecast Analysis - by Country
      • 10.1.2.1 Japan: Asia Pacific Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
        • 10.1.2.1.1 Japan: Asia Pacific Antimicrobial Surgical Suture Market Breakdown, by Type
        • 10.1.2.1.2 Japan: Asia Pacific Antimicrobial Surgical Suture Market Breakdown, by Raw Materials
        • 10.1.2.1.3 Japan: Asia Pacific Antimicrobial Surgical Suture Market Breakdown, by Application
        • 10.1.2.1.4 Japan: Asia Pacific Antimicrobial Surgical Suture Market Breakdown, by End User
      • 10.1.2.2 China: Asia Pacific Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
        • 10.1.2.2.1 China: Asia Pacific Antimicrobial Surgical Suture Market Breakdown, by Type
        • 10.1.2.2.2 China: Asia Pacific Antimicrobial Surgical Suture Market Breakdown, by Raw Materials
        • 10.1.2.2.3 China: Asia Pacific Antimicrobial Surgical Suture Market Breakdown, by Application
        • 10.1.2.2.4 China: Asia Pacific Antimicrobial Surgical Suture Market Breakdown, by End User
      • 10.1.2.3 India: Asia Pacific Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
        • 10.1.2.3.1 India: Asia Pacific Antimicrobial Surgical Suture Market Breakdown, by Type
        • 10.1.2.3.2 India: Asia Pacific Antimicrobial Surgical Suture Market Breakdown, by Raw Materials
        • 10.1.2.3.3 India: Asia Pacific Antimicrobial Surgical Suture Market Breakdown, by Application
        • 10.1.2.3.4 India: Asia Pacific Antimicrobial Surgical Suture Market Breakdown, by End User
      • 10.1.2.4 South Korea: Asia Pacific Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
        • 10.1.2.4.1 South Korea: Asia Pacific Antimicrobial Surgical Suture Market Breakdown, by Type
        • 10.1.2.4.2 South Korea: Asia Pacific Antimicrobial Surgical Suture Market Breakdown, by Raw Materials
        • 10.1.2.4.3 South Korea: Asia Pacific Antimicrobial Surgical Suture Market Breakdown, by Application
        • 10.1.2.4.4 South Korea: Asia Pacific Antimicrobial Surgical Suture Market Breakdown, by End User
      • 10.1.2.5 Australia: Asia Pacific Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
        • 10.1.2.5.1 Australia: Asia Pacific Antimicrobial Surgical Suture Market Breakdown, by Type
        • 10.1.2.5.2 Australia: Asia Pacific Antimicrobial Surgical Suture Market Breakdown, by Raw Materials
        • 10.1.2.5.3 Australia: Asia Pacific Antimicrobial Surgical Suture Market Breakdown, by Application
        • 10.1.2.5.4 Australia: Asia Pacific Antimicrobial Surgical Suture Market Breakdown, by End User
      • 10.1.2.6 Rest of APAC: Asia Pacific Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
        • 10.1.2.6.1 Rest of APAC: Asia Pacific Antimicrobial Surgical Suture Market Breakdown, by Type
        • 10.1.2.6.2 Rest of APAC: Asia Pacific Antimicrobial Surgical Suture Market Breakdown, by Raw Materials
        • 10.1.2.6.3 Rest of APAC: Asia Pacific Antimicrobial Surgical Suture Market Breakdown, by Application
        • 10.1.2.6.4 Rest of APAC: Asia Pacific Antimicrobial Surgical Suture Market Breakdown, by End User

11. Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies
    • 11.2.1 Overview
  • 11.3 Company Market Share Analysis (%), 2023

12. Company Profiles

  • 12.1 TI Medical
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Healthium Medtech Limited
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 Meril Life Sciences Pvt Ltd
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 Johnson & Johnson
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Futura Surgicare Pvt Ltd (Dolphin Sutures)
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Advanced MedTech Solutions Pvt. Ltd.
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 Internacional Farmaceutica SA
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments

13. Appendix

  • 13.1 About The Insight Partners
  • 13.2 Glossary of Terms